Vortioxetine for Newly Diagnosed Glioblastoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vortioxetine for Newly Diagnosed Glioblastoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-06-29		NCT07284628

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cantonal Hospital of Lucerne, Switzerland	2
Cantonal Hospital of St. Gallen	27
Kantonsspital Aarau	20
University Hospital, Basel, Switzerland	243
University Hospital, Zürich	50
University of Zurich	188

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Zurich	Zurich	Switzerland	25